Skip to content

Research at St Andrews

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

Research output: Contribution to journalArticle

  1. 2015
  2. Published

    Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis

    Gillespie, S. H., Mendel, C. M., Phillips, P. P. J. & REMoxTB Consortium, 5 Feb 2015, In : New England Journal of Medicine. 372, 6, p. 577-577 1 p.

    Research output: Contribution to journalLetter

  3. Published

    The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations

    Bowness, R., Boeree, M. J., Aarnoutse, R., Dawson, R., Diacon, A., Mangu, C., Heinrich, N., Ntinginya, N. E., Kohlenberg, A., Mtafya, B., Phillips, P. P. J., Rachow, A., Plemper van Balen, G. & Gillespie, S. H., Feb 2015, In : Journal of Antimicrobial Chemotherapy. 70, 2, p. 448-455 8 p.

    Research output: Contribution to journalArticle

  4. 2013
  5. Published

    Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

    Friedrich, S. O., Rachow, A., Saathoff, E., Singh, K., Mangu, C. D., Dawson, R., Phillips, P., Venter, A., Bateson, A., Boehme, C. C., Heinrich, N., Hunt, R., Boeree, M. J., Zumla, A., McHugh, T. D., Gillespie, S. H., Diacon, A. & Hoelscher, M., 2013, In : The Lancet Respiratory Medicine. 1, 6, p. 462-470 9 p.

    Research output: Contribution to journalArticle

  6. Published

    Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

    Bryant, J. M., Harris, S. R., Parkhill, J., Dawson, R., Diacon, A., van Helden, P., Pym, A., Ahmad Mahayiddin, A., Chuchottaworn, C., Sanne, I. M., Louw, C., Boeree, M. J., Hoelscher, M., McHugh, T. D., Bateson, A. L. C., Hunt, R. D., Mwaigwisya, S., Wright, L., Gillespie, S. H. & Bentley, S. D., Dec 2013, In : The Lancet Respiratory Medicine. 1, 10, p. 786–792 6 p.

    Research output: Contribution to journalArticle

Related by author

  1. Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection

    Kloprogge, F., Hammond, R., Kipper, K., Gillespie, S. H. & Della Pasqua, O., 13 Sep 2019, In : Scientific Reports. 9, 8 p., 13228.

    Research output: Contribution to journalArticle

  2. A tuberculosis molecular bacterial load assay (TB-MBLA)

    Sabiiti, W., Mtafya, B. A., Alferes De Lima, D., Dombay, E., Baron, V. O., Azam, K., Orascova, K., Sloan, D. J. & Gillespie, S. H., 6 Sep 2019, (Accepted/In press) In : Journal of Visualized Experiments.

    Research output: Contribution to journalArticle

  3. Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?

    Kloprogge, F., Hammond, R., Copas, A., Gillespie, S. H. & Della Pasqua, O., 25 Aug 2019, In : Journal of Antimicrobial Chemotherapy. Advance article, 7 p.

    Research output: Contribution to journalArticle

  4. Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status

    Tweed, C. D., Crook, A. M., Dawson, R., Diacon, A. H., McHugh, T. D., Mendel, C. M., Meredith, S. K., Mohapi, L., Murphy, M. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M. & Gillespie, S. H., 14 Aug 2019, In : BMC Pulmonary Medicine. 19, 9 p., 152.

    Research output: Contribution to journalArticle

  5. Model-based relationship between the molecular bacterial load assay and time-to-positivity in liquid culture

    Svensson, R. J., Sabiiti, W., Kibiki, G. S., Ntinginya, N. E., Bhatt, N., Davies, G., Gillespie, S. H. & Simonsson, U. S. H., 29 Jul 2019, In : Antimicrobial Agents and Chemotherapy. Early

    Research output: Contribution to journalArticle

Related by journal

  1. Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

    Murphy, M. E., Wills, G. H., Murthy, S., Louw, C., Bateson, A. L. C., Hunt, R. D., McHugh, T. D., Nunn, A. J., Meredith, S. K., Mendel, C. M., Spigelman, M., Crook, A. M., Gillespie, S. H. & REMoxTB Consortium, 17 Oct 2018, In : BMC Medicine. 16, 11 p., 189.

    Research output: Contribution to journalArticle

  2. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Wills, G. H., Crook, A. M., Dawson, R., Diacon, A. H., Louw, C. E., McHugh, T. D., Mendel, C., Meredith, S., Mohapi, L., Murphy, M. E., Murray, S., Murthy, S., Nunn, A. J., Phillips, P. P. J., Singh, K., Spigelman, M. & Gillespie, S. H., 28 Mar 2018, In : BMC Medicine. 16, 10 p., 46.

    Research output: Contribution to journalArticle

  3. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis

    Murthy, S. E., Chatterjee, F., Crook, A., Dawson, R., Mendel, C., Murphy, M. E., Murray, S. R., Nunn, A. J., Phillips, P. P. J., Singh, K. P., McHugh, T. D., Gillespie, S. H. & REMoxTB Consortium, 21 May 2018, In : BMC Medicine. 16, 11 p., 73.

    Research output: Contribution to journalArticle

  4. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

    Phillips, P. P. J., Mendel, C. M., Nunn, A. J., McHugh, T. D., Crook, A. M., Hunt, R., Bateson, A. & Gillespie, S. H., 24 Nov 2017, In : BMC Medicine. 15, 9 p., 207.

    Research output: Contribution to journalArticle

  5. A review of renal histology in HIV-1 infected individuals on tenofovir disoproxil fumarate (TDF), could there be glomerular involvement?

    Cevik, M., Leen, C. & Raha, D., Apr 2017, In : BMC Medicine. 18, p. 31-31 1 p.

    Research output: Contribution to journalAbstract

ID: 240893266

Top